Label Scale and Rating Scale in Subjective Well-Being Measurement

Author(s):  
Ester Macri
2020 ◽  
pp. 103985622097193
Author(s):  
Phoebe Williamson ◽  
Judy Hope ◽  
Jose Segal ◽  
Lisa Gill ◽  
Michele Orr ◽  
...  

Objective: To review the Hospital Outreach Post-suicidal Engagement (HOPE) service in the first six months of the pilot program in a metropolitan Melbourne setting, including a description of: (a) socio-demographic, health and psychosocial stressors of people referred; (b) method of presentation; (c) interventions provided and (d) outcomes measured. Method: A retrospective case file analysis reviewed the first six months of HOPE service operation. Results: Forty people received HOPE service during the study period, 60% female, mean age 35 years (range 17–58). The majority had previously engaged in self-harm (72.5%) or attempted suicide (67.5%). Stressors included social isolation, relationship breakdown, unemployment, financial stress, medical problems, history of mental illness, exposure to family violence and adverse childhood events. Statistically significant improvements occurred in the Outcome Rating Scale (ORS) and Session Rating Scale (SRS) following intervention. There were no deaths by suicide during the study period. Conclusion: People referred to HOPE had significant health and psychosocial stressors. Engagement significantly improved subjective well-being and connection with supports. Findings highlighted the need for an integrated clinical and psychosocial model to promote hope and connection in life post suicide attempt. It remains unclear which interventions improved well-being and if this contributes to suicide prevention.


Neurology ◽  
2019 ◽  
Vol 93 (10) ◽  
pp. e938-e945 ◽  
Author(s):  
Magdalena Kuzma-Kozakiewicz ◽  
Peter M. Andersen ◽  
Katarzyna Ciecwierska ◽  
Cynthia Vázquez ◽  
Olga Helczyk ◽  
...  

ObjectiveThis is an observational study on well-being and end-of-life preferences in patients with amyotrophic lateral sclerosis (ALS) in the locked-in state (LIS) in a Polish sample within the EU Joint Programme–Neurodegenerative Disease Research study NEEDSinALS (NEEDSinALS.com).MethodsIn this cross-sectional study, patients with ALS in LIS (n = 19) were interviewed on well-being (quality of life, depression) as a measure of psychosocial adaptation, coping mechanisms, and preferences towards life-sustaining treatments (ventilation, percutaneous endoscopic gastroscopy) and hastened death. Also, clinical data were recorded (ALS Functional Rating Scale–revised version). Standardized questionnaires (Anamnestic Comparative Self-Assessment [ACSA], Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW), ALS Depression Inventory–12 items [ADI-12], schedule of attitudes toward hastened death [SAHD], Motor Neuron Disease Coping Scale) were used, which were digitally transcribed; answers were provided via eye-tracking control. In addition, caregivers were asked to judge patients' well-being.ResultsThe majority of patients had an ACSA score >0 and a SEIQoL score >50% (indicating positive quality of life) and ADI-12 <29 (indicating no clinically relevant depression). Physical function did not reflect subjective well-being; even more, those with no residual physical function had a positive well-being. All patients would again choose the life-sustaining techniques they currently used and their wish for hastened death was low (SAHD <10). Caregivers significantly underestimated patient's well-being.InterpretationSome patients with ALS in LIS maintain a high sense of well-being despite severe physical restrictions. They are content with their life-sustaining treatments and have a strong will to live, which both may be underestimated by their families and public opinion.


2006 ◽  
Vol 8 (1) ◽  
pp. 131-136 ◽  

The patients' perspective of antipsychotic treatment was largely neglected for a long period. It has only been during the last 10 years, with the development of atypical antipsychotics, that scientific interest in this issue has markedly increased. Numerous studies have shown that the majority of schizophrenic patients are able to fill out a self-rating scale in a meaningful way, and several self-report scales with sufficient internal consistency and good construct validity have been developed. The effects of antipsychotic treatment on psychopathology and on subjective well-being (SW) are not strongly related; the perspectives of the patient and his/her psychiatrist markedly differ. Recent research indicates that SW/quality of life, much more improved by atypical than by typical antipsychotics, has a strong impact on compliance, as well as on the chance of achieving remission. The data strongly suggest that a systematic evaluation of the patient's perspective of antipsychotic treatment is meaningful and necessary to increase compliance, functional outcome, and long-term prognosis.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Teerapat Teetharatkul ◽  
Arnont Vitayanont ◽  
Tippawan Liabsuetrakul ◽  
Warut Aunjitsakul

Abstract Background Severity of symptoms in patients with schizophrenia is a determinant of patient’s well-being, but evidence in low- and middle-income countries is limited. We aimed to measure the symptom severity using objective measurements, the Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression-Severity scale (CGI-S), and their associations with well-being in patients with schizophrenia. Methods Patients with schizophrenia aged ≥18 years, without active psychosis including no history of hospitalization within the last 6 months, were included. Symptom severity was measured by the clinicians using BPRS and CGI-S. The patients’ well-being was assessed by self-report using the Subjective Well-being under Neuroleptic treatment scale (SWN) as continuous and binary outcomes (categorized into adequate or poor well-being). Correlations between symptom severity (BPRS and CGI-S scores) and well-being (SWN score) were analyzed using Pearson’s correlation. Association between well-being status and BPRS was analyzed using multivariate logistic regression. Results Of 150 patients, BPRS and CGI-S were inversely correlated with SWN score (r = − 0.47; p < 0.001 and − 0.21; p < 0.01, respectively). BPRS Affect domain had the highest correlation with SWN (r = − 0.51, p < 0.001). In multivariate logistic regression, BPRS score and being unemployed were associated with poor well-being status (adjusted OR 1.08; 95%CI 1.02–1.14; p = 0.006, and 4.01; 95%CI 1.38–11.7; p = 0.011, respectively). Conclusion Inverse relationships between symptom severity and well-being score were found. Higher BPRS Affect domain was significantly associated with lower patients’ well-being. The use of BPRS tool into routine clinical practice could serve as an adjunct to physician’s clinical evaluation of patients’ symptoms and may help improve patient’s well-being. Further research on negative symptoms associated with well-being is required.


2021 ◽  
Vol 19 (3) ◽  
pp. 2364
Author(s):  
Zeinab Bitar ◽  
Chadia Haddad ◽  
Sahar Obeid ◽  
Souheil Hallit

Background: The patient's evaluation of treatment and its associated outcomes define the treatment satisfaction. The quality of treatment satisfaction and healthcare service has been affected by depression, anxiety and fear of the current coronavirus disease 2019 (COVID-19) pandemic. Objective: Therefore, this study aimed to assess factors associated with treatment satisfaction among Lebanese inpatients with schizophrenia, namely depression, anxiety and fear of COVID-19. Methods: A cross-sectional study was conducted between September and November 2020, enrolled 118 patients with chronic schizophrenia consecutively admitted to Psychiatric Hospital of the Cross, Lebanon. The Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction-Patient Satisfaction Scale (FACIT-TS-PS) was used to assess treatment satisfaction, the Lebanese Anxiety Scale -10 (LAS-10) was used to assess anxiety, Montgomery-Asberg Depression Rating Scale (MADRS) to assess depression and the Fear of COVID-19 Scale to assess the level of fear of the COVID-19 pandemic. Results: The mean scores of the scales were as follows: treatment satisfaction (65.20; SD 16.11; median=71), LAS-10 (13.65; SD 6.02), MADRS (9.09; SD 6.69) and fear of COVID-19 (18.59; SD 6.78). Higher depression (r= -0.46, p<0.001) was significantly associated with lower treatment satisfaction. Female gender (beta=7.51, p=0.029) was significantly associated with higher treatment satisfaction score. Fear of COVID-19 did not show any significant association with the treatment satisfaction score. Conclusions: Results of this study found that depression and gender were associated with treatment satisfaction among inpatients with schizophrenia. No association has been found between fear of COVID-19 and treatment satisfaction among those patients. More research is warranted to evaluate treatment satisfaction and associated factors among chronic inpatients with schizophrenia, specifically during the COVID-19 pandemic, in order to improve treatment satisfaction and subjective well-being of patients.


2018 ◽  
Vol 35 (1) ◽  
pp. 53-63
Author(s):  
Lucas de Francisco CARVALHO ◽  
Cristian ZANON ◽  
Rodolfo Augusto Matteo AMBIEL ◽  
Carla Fernanda FERREIRA-RODRIGUES

Abstract Positive Psychology has gained momentum in the international scenario, and one of its first constructs that has been studied in Brazil is subjective well-being. This study aims to verify the Escala de Bem-Estar Subjetivo (Subjective Well-Being Scale) Scale’s psychometric properties by independently applying the Item Response Theory’s rating scale model to each scale component. Evidence of validity was verified based on internal structure and reliability coefficients, which were assessed through internal consistency. In order to do so, a subject database consisting of 182 male and female college students aged between 18 and 57 years old was used (mean age of 24.6 years). Results showed evidence of unidimensionality of all three factors of the scale. In addition, only one of the factors’ response category did not have the expected results. Participants tended to choose mostly Positive Affect items, and negative affect had the lowest theta average. The implications of these findings to the instrument’s psychometric quality are thoroughly discussed.


2020 ◽  
Vol 1 (3) ◽  
Author(s):  
Yongmei HOU ◽  
Zixu Guo ◽  
Que Zheng

Objective: To explore the the status of happiness and social support of empty nesters in Guangdong Province and analyze the relationship between the above two variables.Method: Totally 1148 empty nesters (776 males, 734 females) from 5 cities in Guangdong province are selected by stratified random sampling and conducted with Memorial University of Newfoundland Scale of Happiness (MUNSH), Social Support Rating Scale (SSRS), Mini-Mental State Examination (MMSE) and a self-edited questionnaire on the general information.Results: The total score of MUNSH is (10.20±6.37). The total score and the scores of the 3 dimensions of objective support, subject support, the use of support in SSRS are (30.79±5.51), (9.24±2.37), (19.38±4.95) and (9.22±2.15) respectively. Multiple variable linear regression show that are positively associated with the total scores of MUNSH (B= .227, .115, .098,.158,.082,respectively, P<.05). was negatively associated with total score of MUNSH (B=-.097,P<.05).Conclusion:It suggests that the sort of leisure, gender, progress rank, family characteristics, such as family economic condition and father's career may be related factors of undergraduates life satisfaction.


2019 ◽  
Vol 11 (23) ◽  
pp. 6627 ◽  
Author(s):  
Attila Lengyel ◽  
Sándor Kovács ◽  
Anetta Müller ◽  
Dávid Lóránt ◽  
Szilvia Szőke ◽  
...  

Sustainability and Subjective Well-Being (SWB) are strongly interrelated domains. The way students view them and prioritize their dimensions should be factored into curricular developments in education for sustainability. Instruments developed to examine sustainability and SWB preferences typically use rating scale items to measure dimensions as separate entities. In contrast, the question format used in this study forces the students to rate variables in relation to each other. The sum of both SWB and sustainability variables was fixed, which means that increasing the weight of a priority automatically meant a decrease in the weight that could be allocated for the remaining elements. Two-block Partial Least Squares (PLS) modelling was used to examine how pre-defined SWB and sustainability dimensions behave when handled within the same model. It was found that those who ordered the three sustainability dimensions as Environment > Society > Economy tended to rank SWB dimensions as (Relations with others, Inner peace) > (Health, Close to nature) > (Good job, Leisure). Our research proved that the use of question formats resembling real-life resource allocation dilemmas and the treatment of SWB and sustainability as one system can yield invaluable information for the educational process.


2007 ◽  
Vol 22 (3) ◽  
pp. 195-202 ◽  
Author(s):  
Duerten Kudla ◽  
Martin Lambert ◽  
Sabine Domin ◽  
Siegfried Kasper ◽  
Dieter Naber

AbstractPurposeThe ZEISIG study (Ziprasidone Experience in Schizophrenia in Germany/Austria) investigated the effectiveness of ziprasidone as measured by discontinuation rates and mean changes of the BPRS total. Secondary objectives included quality of life, subjective well-being, tolerability, and safety.Subjects and methodsTwo hundred and seventy-six subjects with schizophrenia and schizoaffective disorder were treated within an open-label, 12-week, prospective, flexible-dose observational trial of ziprasidone (40–160 mg/day). Baseline and outcome assessments mainly included Brief Psychiatric Rating Scale (BPRS), Clinical Global Impressions Scale (CGI), Short-Form 12 (SF-12), and Subjective Well-being under Neuroleptic treatment (SWN-K).ResultsStudy discontinuation due to any cause was evident in 58% of subjects, most of them within the first 4 weeks after study initiation. In study completers, ziprasidone was associated with improvements in BPRS total (44.8 to 33.6; p < 0.001), CGI, SF-12, and SWN-K total scores (80.5 to 89.5). Ziprasidone was related to reduction of weight, fasting glucose, and serum lipids. No cardiovascular adverse event or significant increase of the QTc interval was observed.Discussion and conclusionApproximately 60% of subjects discontinued ziprasidone prematurely, probably related to an initial and overall underdose. The present study confirmed previous tolerability and safety data of ziprasidone as well as results of its effectiveness. Independent from reason to switch, previous antipsychotic class, and severity of illness at baseline, the recommended starting dose of 80 mg/day as well as the maximum treatment dose of 160 mg/day may not be sufficient for a selected subgroup of patients.


2011 ◽  
Vol 26 (S2) ◽  
pp. 208-208
Author(s):  
M. Freidl ◽  
F. Friedrich ◽  
G. Kaiser ◽  
J. Wancata

IntroductionNon-adherence of medication still is a major problem among patients suffering from bipolar disorders.ObjectivesPrevious studies focused mainly on possible side-effects, attitudes and subjective well-being. Most scales concerning this issue have been developed by psychiatric experts and based on their knowledge not on the patients points of view.AimsThe purpose of this study was to find out what kind of drug effects the patients themselves want.Methods2 focus-groups with 13 patients and In-depth interviews with 15 mania patients were conducted to collect information about subjective burden and symptoms of the illness. Content analyses of the transcriptions were performed and the results were used to develop a first draft of the questionnaire.ResultsThe final German test version consists of 32 items and is called “The Subjective Mania Scale”. The study of content-validity showed that all SMS items were considered to be important by more than 50% of the sample. Test-retest reliability and sensitivity to change were evaluated. All SMS-items showed a significant change between time-point 1 and 3.ConclusionThe SMS-rating scale is a feasible, reliable and valid instrument for clinical trials among mania patients.


Sign in / Sign up

Export Citation Format

Share Document